Nonfasting screening for cardiovascular risk among individuals taking second-generation antipsychotics

Erik R. Vanderlip, Lydia A. Chwastiak, Robert M. McCarron

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Ischemic heart disease (IHD) is the leading cause of mortality among adults with severe mental illness. Although gains in reducing mortality fromIHDthrough screening, risk reduction, and early intervention have been realized for the general public, rates of recognition and treatment among individuals with mental illness continue to be poor. Obtaining blood samples from patients who have been fasting for eight to 12 hours is challenging for adults with severe mental illness and presents an additional obstacle to screening and treatment. This column outlines newer guidelines for cholesterol and diabetes screening that provide valid alternatives to fasting blood draws, thereby significantly reducing this common barrier to recognition of leading risk factors for IHD.

Original languageEnglish (US)
Pages (from-to)573-576
Number of pages4
JournalPsychiatric Services
Issue number5
StatePublished - May 1 2014

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine(all)


Dive into the research topics of 'Nonfasting screening for cardiovascular risk among individuals taking second-generation antipsychotics'. Together they form a unique fingerprint.

Cite this